7V91 Stock Chart & Stats
€0.16
>-€0.01(-1.17%)
At close: 4:00 PM EST
€0.16
>-€0.01(-1.17%)
Day’s Range― - ―
52-Week Range€0.15 - €0.30
Previous CloseN/A
Volume0.00
Average Volume (3M)1.75K
Market Cap
€48.58M
Enterprise Value€67.47M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.6
Beta0.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding307,514,300
10 Day Avg. Volume632
30 Day Avg. Volume1,750
Financial Highlights & Ratios
PEG Ratio0.67
Price to Book (P/B)2.44
Price to Sales (P/S)3.04
P/FCF Ratio17.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)€24.40M
Visiomed Group SA News
7V91 FAQ
What was Visiomed Group SA’s price range in the past 12 months?
Visiomed Group SA lowest stock price was €0.15 and its highest was €0.30 in the past 12 months.
What is Visiomed Group SA’s market cap?
Visiomed Group SA’s market cap is €48.58M.
When is Visiomed Group SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Visiomed Group SA’s earnings last quarter?
Currently, no data Available
Is Visiomed Group SA overvalued?
According to Wall Street analysts Visiomed Group SA’s price is currently Overvalued.
Does Visiomed Group SA pay dividends?
Visiomed Group SA does not currently pay dividends.
What is Visiomed Group SA’s EPS estimate?
Visiomed Group SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Visiomed Group SA have?
Visiomed Group SA has 307,514,300 shares outstanding.
What happened to Visiomed Group SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Visiomed Group SA?
Currently, no hedge funds are holding shares in DE:7V91
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Visiomed Group SA
Klea Holding SA, along with its subsidiaries, provides healthcare technology solutions and related services across France and internationally. The company's key offerings include BewellConnect, a comprehensive health ecosystem that facilitates augmented and assisted teleconsultation, remote patient monitoring for both home and hospital settings, tele-expertise, virtual assistance, and remote regulatory services. Additionally, Klea Holding SA markets Smart Salem, a specialized device for medical fitness assessments. Founded in 2007 and headquartered in Paris, France, the company operated under the name Visiomed Group SA until it rebranded to Klea Holding SA in June 2024.
Technical Analysis
Novacyt
―
Eurobio-Scientific SA
―
Diagnostic Medical Systems
―
Biosynex SA
―
ABL Diagnostics SA
―






